BamSEC and AlphaSense Join Forces
Learn More

Inhibikase Therapeutics Inc. – Transcripts

NASDAQ: IKT    
Share price (11/6/26): $1.50    
Market cap (11/6/26): $209 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2025
Other Revised 06/27/25 Inhibikase Therapeutics, Inc. - Shareholder/Analyst Call 06/27/25
CY 2024
Earnings Revised 08/15/24 Inhibikase Therapeutics, Inc., Q2 2024 Earnings Call, Aug 15, 2024 08/15/24
Earnings Revised 05/16/24 Inhibikase Therapeutics, Inc., Q1 2024 Earnings Call, May 16, 2024 05/16/24
Earnings Revised 03/28/24 Inhibikase Therapeutics, Inc., 2023 Earnings Call, Mar 28, 2024 03/28/24
CY 2023
Earnings Revised 11/15/23 Inhibikase Therapeutics, Inc., Q3 2023 Earnings Call, Nov 15, 2023 11/15/23
Earnings Revised 03/19/24 Inhibikase Therapeutics, Inc., Q2 2023 Earnings Call, Aug 15, 2023 08/15/23
Earnings Revised 05/17/23 Inhibikase Therapeutics, Inc., Q1 2023 Earnings Call, May 16, 2023 05/16/23
Earnings Revised 04/05/23 Inhibikase Therapeutics, Inc., Q4 2022 Earnings Call, Apr 03, 2023 04/03/23
Other Revised 09/10/24 Inhibikase Therapeutics, Inc. - Special Call 03/22/23
CY 2022
Earnings Revised 11/15/22 Inhibikase Therapeutics, Inc., Q3 2022 Earnings Call, Nov 15, 2022 11/15/22